Mean age 68.3, range: 45–84 y 67.4, range: 46–82 y 0.47
Male 19 (86.4) 23 (76.7) 0.071
Marital status 0.87
Married 16 (72.7) 20 (66.7)
Separated 2 (9.1) 5 (16.7)
Single 1 (4.5) 3 (10.0)
Widowed 3 (13.6) 2 (6.67)
Family caregiver identified 19 (86.4) 26 (86.7) 0.40
Education level 0.74
Middle 1 (4.5) 1 (3.3)
High School 7 (31.8) 10 (33.3)
College 7 (31.8) 12 (40.0)
Graduate school 7 (31.8) 7 (23.3)
Religion 0.24
Other 2 (9.1) 1 (3.3)
Christian 13 (59.1) 25 (83.3)
Buddhist 4 (18.2) 0 (0)
None 3 (13.6) 4 (13.3)
Muslim 0 (0) 0 (0)
Jewish 0 (0) 0 (0)
Multiple comorbidities 20 (90.9) (mean ¼ 3.5,
range: 1–8)
28 (93.3) (mean ¼ 4.3,
range: 1–10)
0.01
Three most common comorbidities
Hypertension 11 (50) 20 (66.7)
Dyslipidemia 11 (50) 15 (50.0)
Coronary artery disease 6 (27.3)
GERD 10 (33.3)
Prior diagnosis of anxiety or depression or both 5 (22.7) 6 (20.0) 0.22
Prior treatment 0.001
TURBT 22 (100) 10 (33.3)
TURBT þ Intravesical therapy 9 (40.9) 7 (23.3)
TURBT þ Neoadjuvant chemotherapy 4 (18.2) 11 (36.7)
TURBT þ other 2 (6.7)
Diversion method 0.82
Neobladder 7 (31.8) 10 (33.3)
Ileal conduit 15 (68.2) 20 (66.7)
Tumor stage 0.001
In Situ 1 (4.6) 2 (6.7)
Stage 1 6 (27.3) 2 (6.7)
Stage 2 9 (40.9) 11 (36.7)
Stage 3 4 (18.2) 2 (6.7)
Stage 4 2 (9.1) 13 (43.3)
Postoperative health care utilization
Mean Number of Bladder Cancer Program visits 2.3 Unknown
Emergency Department visits 7 (32% of patients had ED visits) 11 (36.7% of patients had ED visits) 0.31
Number of subsequent hospitalizations 5 (22.7% of patients were
hospitalized)
11 (36.7% of patients were
hospitalized)
0.001
Median number of days in hospital for subsequent
hospitalizations
1.8 4 0.001
Postoperative mortality
6 Months 0 1 (3.3%) 0.32
1 Year 0 3 (10%) 0.80
2 Years 0 5 (17.9%) 0.02